Kenneth C. Anderson: Pioneering Advances in Multiple Myeloma Treatment

Kenneth C. Anderson, MD, is a leading figure in the field of hematology-oncology, renowned for his groundbreaking contributions to the understanding and treatment of multiple myeloma. As the Kraft Family Professor of Medicine at Harvard Medical School and Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute, Dr. Anderson has dedicated over four decades to advancing the care of patients with this challenging blood cancer.

Early Life and Education

Dr. Anderson received his medical degree from Johns Hopkins Medical School. He completed his training in internal medicine at Johns Hopkins Hospital, followed by specialized fellowships in hematology, medical oncology, and tumor immunology at the Dana-Farber Cancer Institute. Dana-Farber Cancer Institute

Research Focus and Contributions

Dr. Anderson’s research has centered on unraveling the complexities of multiple myeloma, focusing on the tumor microenvironment and identifying novel therapeutic targets. He has developed innovative laboratory and animal models to study the disease, which have been instrumental in validating new targeted therapies and translating these discoveries into clinical trials. International Myeloma Society His function has led to FDA approval of several novel targeted and immune therapies, significantly improving outcomes for patients with multiple myeloma.

His paradigm for identifying and validating targets within the tumor and its surrounding environment has fundamentally transformed myeloma therapy. Dana-Farber Brigham

Leadership Roles and Recognition

Beyond his research, Dr. Anderson holds several prestigious leadership positions. He is a Doris Duke Distinguished Clinical Research Scientist and an American Cancer Society Clinical Research Professor. He previously served as President of the International Myeloma Society. International Myeloma Society

Dr. Anderson has received numerous awards and honors for his contributions to the field, including:

• The International Myeloma Workshop Waldenström’s Award
• The International Myeloma Foundation Robert A. Kyle Lifetime Achievement Award
• The American Association for Cancer Research Joseph H. Burchenal Award
• The American Society of Hematology William Dameshek Prize
• The Harvard Medical School Warren Alpert Foundation Prize
• The American Cancer Society Medal of Honor in Science

Current Affiliations

As of February 2026, Dr. Anderson maintains the following affiliations:

• Kraft Family Professor of Medicine, Harvard Medical School
• Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

Contact Information

For appointments or further information, Dr. Anderson can be reached at:

• Office Phone: 617-632-2144
• Fax: 617-632-2140
• Appointments: 617-632-2144

Dr. Anderson’s continued dedication to research and patient care promises further advancements in the fight against multiple myeloma.